Vitamin K [EPC]

6214 reported adverse events

Drugs of this class: PHYTONADIONE ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN ARNICA MONTANA, CALENDULA OFFICINALIS, CARDUUS MARIANUS, GRAPHITES, HYPERICUM PERFORATUM, STAPHYSAGRIA, THIOSINAMINUM, VITAMIN K1 ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN VITAMIN K1 - PHYTONADIONE VITAMIN K1, PHYTONADIONE

These side effects are most commonly reported by patients taking drugs of the Vitamin K [EPC] class:

#	Side effect	Count
0	NAUSEA	390
1	FATIGUE	350
2	DYSPNOEA	320
3	DIARRHOEA	312
4	OFF LABEL USE	311
5	VOMITING	311
6	PYREXIA	257
7	SEPSIS	248
8	HEADACHE	233
9	DRUG INEFFECTIVE	232

See all common reactions for Vitamin K [EPC]

Drugs of the Vitamin K [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	APPENDICOLITH	78	0.6724
1	HAEMORRHAGE NEONATAL	6	0.1395
2	HYPER IGE SYNDROME	11	0.1264
3	CYSTIC FIBROSIS RELATED DIABETES	6	0.0750
4	TERMINAL ILEITIS	8	0.0630
5	FACTOR V INHIBITION	10	0.0575
6	VITAMIN K DEFICIENCY	15	0.0523
7	RENAL VASCULAR THROMBOSIS	6	0.0500
8	DISTAL INTESTINAL OBSTRUCTION SYNDROME	10	0.0478
9	INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS	217	0.0473

See all enriched reactions for Vitamin K [EPC]